Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Market Cap	44.40B
Revenue (ttm)	2.22B
Net Income (ttm)	-1.32B
Shares Out	1.03B
EPS (ttm)	-1.34
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,760,400
Average Volume	16,267,511
Open	31.00
Previous Close	30.74
Day's Range	30.80 - 33.06
52-Week Range	9.72 - 32.76
Beta	0.57
RSI	60.77
Earnings Date	Aug 27, 2025

About HKG:1877

Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 2,578
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1877

Financial Performance

In 2024, HKG:1877's revenue was 1.95 billion, an increase of 29.67% compared to the previous year's 1.50 billion. Losses were -1.28 billion, -43.90% less than in 2023.

Financial numbers in CNY